FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental ANDA for deferoxamine mesylate submitted by Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Iron Poisoning

Drugs mentioned

• Deferoxamine Mesylate (Deferoxamine)

Snippet

SUPPL AP for DEFEROXAMINE MESYLATE (DEFEROXAMINE MESYLATE)